Cross-Border Medical Tourism and Clinical Negligence: The Jurisdictional Challenges of International Healthcare Litigation

Cross-Border Medical Tourism and Clinical Negligence: The Jurisdictional Challenges of International Healthcare Litigation

Hardi Goradia | Specialist Healthcare Law

India receives approximately five million medical tourists annually. They arrive from the Gulf states, Africa, South-East Asia, the United Kingdom, and beyond, drawn by the combination of clinical expertise, hospital infrastructure, and pricing that positions Indian healthcare as one of the most commercially significant medical tourism destinations in the world. The India Brand Equity Foundation estimates the medical tourism sector at several billion dollars and growing. For a significant proportion of those patients, the clinical outcome is exactly what was sought: high-quality treatment at a fraction of the cost available in their home jurisdiction. For a smaller but legally consequential subset, something goes wrong.

When it does, what follows is not a medical negligence case in any conventional sense. It is an exercise in navigating the fault lines of international private law — a discipline that most domestic medical negligence practitioners have neither encountered nor anticipate. The injured foreign patient seeking legal redress confronts questions of jurisdictional competence, applicable law, cross-border evidence, insurance coverage architecture, and the enforceability of any ultimate judgment long before the clinical merits of their claim are examined. These are not procedural inconveniences. They are structural features of cross-border healthcare litigation that determine whether a claim is viable at all, in which forum it can be advanced, and under whose law its outcome will be assessed.

This article examines those structural features. Its purpose is not to dissuade international patients from seeking redress — it is to map the genuine complexity that distinguishes medical tourism litigation from the domestic medical negligence claim, and to identify the specialist legal framework within which that complexity must be navigated.

The Medical Tourism Claim Is Not a Medical Negligence Claim

The tendency to characterise medical tourism injuries as medical negligence disputes is understandable but analytically incomplete. A domestic medical negligence claim involves, at its core, a single question: did the defendant's clinical conduct fall below the applicable standard of care, and did that departure cause the claimant's harm? The legal relationships are relatively simple, the forums are defined by domestic statute, and the applicable law is unambiguous.

A medical tourism injury claim involves that question — but overlaid with a cluster of separate legal relationships that may be governed by different legal systems, adjudicated in different forums, and enforced through different institutional mechanisms simultaneously. The relationship between the patient and the treating hospital may be governed by Indian contract law and the Consumer Protection Act 2019, with clinical liability assessed against the standards articulated by the Supreme Court in Kusum Sharma v Batra Hospital and Research Centre (2010) and Jacob Mathew v State of Punjab(2005). The relationship between the patient and the medical tourism facilitator who arranged the treatment may be governed by the law of the patient's home jurisdiction, as the contract was concluded there. The relationship between the facilitator and the hospital may involve an agency or referral agreement governed by Indian contract law with a specific choice of forum clause. The patient's travel insurance or health insurance policy may be governed by yet another legal system. And the question of where any of these claims can ultimately be litigated — and where any resulting judgment can be enforced — is answered by principles of private international law that cut across all of these relationships.

These are not the same dispute. They are different legal problems, arising from the same clinical incident, that require simultaneous analysis across multiple legal frameworks.

Jurisdictional Complexity: Where Can Proceedings Be Commenced?

The threshold question in any cross-border dispute is deceptively simple: which court or forum has jurisdiction to hear the claim? In a medical tourism case, the answer is rarely straightforward.

Indian courts exercise jurisdiction over medical negligence claims arising from treatment delivered in India as a matter of course. The Code of Civil Procedure 1908 confers jurisdiction on civil courts at the location of the defendant — the hospital, the clinician — and the Consumer Protection Act 2019 provides an additional forum through State Consumer Disputes Redressal Commissions and the National Consumer Disputes Redressal Commission. For a foreign national harmed in an Indian hospital, access to these forums is available in principle: the Consumer Protection Act's definition of "consumer" and "service" encompasses international patients, and the NCDRC has jurisdiction over claims exceeding ₹1 crore. The procedural accessibility of Indian forums, however, involves practical challenges — geographic distance, language, the need for Indian legal representation, and the time horizons of Indian litigation — that make forum selection a strategic rather than automatic decision for an international claimant.

Can the patient sue in their home jurisdiction? This is the question most international claimants ask first, and the answer is highly jurisdiction-dependent. In England and Wales, the Civil Jurisdiction and Judgments Act 1982 and the common law rules governing service out of the jurisdiction permit English courts to exercise jurisdiction over foreign defendants in certain circumstances — but establishing jurisdiction over an Indian hospital or clinician before an English court requires the claim to connect with English law in a way that medical treatment delivered entirely in India typically does not. The English courts' general reluctance to exercise exorbitant jurisdiction over foreign defendants, reinforced by the forum non conveniens doctrine first articulated at the House of Lords level in Spiliada Maritime Corp v Cansulex Ltd (1987), means that a claimant who brings proceedings in England against an Indian hospital will likely face a jurisdictional challenge arguing that India is the clearly more appropriate forum. That argument carries significant weight: the witnesses are in India, the medical records are in India, the treating clinicians are in India, and the clinical standards by which the conduct should be assessed are Indian standards.

European claimants face similar analysis under the Brussels I Regulation (Recast) or its successor frameworks — jurisdiction over defendants domiciled outside the EU follows national rules, which generally lead back toward the jurisdiction of the defendant's domicile. American, Gulf, and African claimants operate within their own domestic jurisdiction frameworks, but the structural dynamic is consistent: domestic courts are generally reluctant to assert jurisdiction over foreign defendants when the facts connecting the dispute to the domestic forum are limited.

The consequence of this jurisdictional analysis is frequently that the international patient is directed back toward Indian forums, with all the practical challenges that entails, or toward whatever contractual forum has been stipulated in the agreements governing the treatment relationship.

Choice of Law: Whose Legal System Governs the Dispute?

Jurisdiction and applicable law are distinct questions, though they are often conflated. A court may have jurisdiction to hear a dispute but apply foreign law to determine its substantive outcome. In cross-border medical tourism cases, the choice of law question is analytically significant and practically consequential.

The general principle in private international law is that tortious claims are governed by the law of the place where the tort was committed — the lex loci delicti. In a medical tourism case where clinical treatment was delivered in India, this principle directs the court toward Indian law as the governing substantive law for the negligence claim, regardless of which forum is conducting the litigation. Under English law, the Private International Law (Miscellaneous Provisions) Act 1995 confirms the lex loci delicti as the starting point, subject to a flexible exception where another law has a substantially more significant connection. The EU's Rome II Regulation governs the same question for European courts.

The practical consequence is that an Indian hospital's clinical conduct is likely to be assessed against Indian standards of care — the Bolam-derived standard as modified by the Supreme Court in Kusum Sharma, the informed consent doctrine as it has developed in Indian courts, and the causation analysis that Indian law applies — even if the litigation is conducted before a court in the United Kingdom or Germany. This creates significant evidential complexity: a foreign court must receive expert evidence on Indian medical standards, engage with Indian statutory and case law, and apply a legal framework that its judges may not routinely encounter.

Where contractual relationships exist alongside the tortious claim — as is common in medical tourism, where a formal agreement for treatment services may have been entered into between the patient and the hospital or facilitator — the contractual claim is governed by the law applicable to the contract. This is determined by the Rome I Regulation (for European courts) or by common law contractual choice of law principles. Sophisticated hospital groups and medical tourism facilitators regularly include choice of law and choice of forum clauses in their patient service agreements. Where such a clause directs disputes to Indian courts applying Indian law, it will generally be enforced by the courts of most major jurisdictions — provided it does not conflict with the mandatory consumer protection provisions of the patient's home jurisdiction.

Those mandatory consumer protection provisions are precisely the complication. Many jurisdictions — including EU member states, the UK, and Australia — have consumer protection legislation that cannot be excluded by contractual choice of law or forum. A patient who is a consumer within the meaning of their home jurisdiction's consumer protection framework may retain rights under that framework regardless of what the Indian service agreement provides.

The Medical Tourism Facilitator: An Underestimated Legal Exposure

The involvement of a medical tourism facilitator — a commercial intermediary that arranges treatment, provides information about clinical options, handles logistics, and in some cases makes clinical representations about the quality or suitability of care — creates a separate and often underestimated layer of legal exposure.

The facilitator's legal position depends on the nature of its role in the transaction. If it acts as an agent for the hospital — introducing patients and receiving a referral fee — it may carry limited direct liability for clinical outcomes but significant exposure for misrepresentations made during the introduction process. If the facilitator represents itself as curating and quality-assuring the hospitals it recommends, or makes representations about clinical outcomes, accreditation, or the qualifications of treating clinicians that turn out to be inaccurate or misleading, it faces potential liability in misrepresentation — including under consumer protection legislation in the patient's home jurisdiction — that is independent of the hospital's clinical liability.

The facilitator is typically incorporated and operating in the patient's home jurisdiction, which resolves the jurisdictional access problem that the hospital's foreign location creates: proceedings against the facilitator can be brought at home, under familiar law, before accessible courts. This makes the facilitator a more immediately accessible defendant than the Indian hospital, and explains why in practice, medical tourism litigation increasingly targets the facilitator alongside — or occasionally instead of — the treating institution. The facilitator's exposure to misrepresentation and agency liability claims under the law of its home jurisdiction is an area of legal risk that is systematically underestimated in the medical tourism industry.

Enforcement: The Gap Between Judgment and Recovery

Even where a claimant successfully obtains a judgment — whether from an Indian forum or a foreign court — the question of enforcement is separate and frequently the most practically significant obstacle to actual recovery.

Indian courts do not automatically enforce foreign judgments. The Code of Civil Procedure 1908, under Sections 13 and 44A, provides the framework for the recognition of foreign judgments in India. Section 44A permits the direct enforcement of judgments from "reciprocating territories" — a specific list of countries gazetted by the Indian government, which includes the United Kingdom and several Commonwealth jurisdictions. For judgments from non-reciprocating territories — including most European Union member states and the United States — enforcement requires fresh proceedings in India, with the foreign judgment treated as merely persuasive evidence of the relevant facts rather than as a binding determination. This bifurcation of the enforcement regime creates substantial practical asymmetry: a claimant who obtains judgment in a reciprocating territory jurisdiction has a realistic enforcement path in India; a claimant from a non-reciprocating jurisdiction faces the prospect of substantially re-litigating their claim in Indian courts simply to access the judgment debtor's Indian assets.

The converse question — the enforceability of Indian judgments in foreign jurisdictions — is equally complex. English courts will recognise and enforce Indian judgments that meet the common law requirements for the recognition of foreign judgments: the Indian court must have had jurisdiction in the private international law sense, the judgment must be final and conclusive, for a definite sum, and must not have been obtained by fraud or in breach of natural justice. In practice, Indian consumer forum decisions and NCDRC awards are not self-evidently equivalent to judgments of the civil courts for the purpose of English enforcement proceedings — a distinction that adds a further layer of procedural complexity to the enforcement analysis.

Cross-Border Evidence and the Practical Obstacles to Litigation

The evidentiary challenges of medical tourism litigation are considerable and routinely underestimated by claimants and their advisors. The clinical records are in India, maintained in formats — handwritten notes, local EMR systems, Hindi-language annotations — that may require both translation and expert contextualisation before they are of evidentiary utility in foreign proceedings. Expert witnesses on the applicable standard of care must be Indian clinicians with expertise in the relevant sub-specialty, able to opine on what Indian clinical standards required at the time of the treatment — not what contemporary international standards require with the benefit of hindsight. Securing that expert evidence from abroad, preparing witnesses for examination in a foreign forum, and managing the translation and authentication requirements for Indian clinical documents across multiple jurisdictions is logistically demanding and expensive.

Where cross-border letters of request or mutual legal assistance frameworks exist, they may assist with documentary evidence. In practice, however, the Hague Evidence Convention framework — though India and many claimant-home jurisdictions are signatories — operates slowly and unpredictably. Medical records in Indian hospital custody do not reliably emerge through formal evidence-gathering routes on timescales that align with foreign litigation timetables.

Insurance Architecture in Cross-Border Claims

The insurance dimension of medical tourism litigation is architecturally complex. The treating Indian clinician or hospital may carry professional indemnity coverage from an Indian insurer, providing cover for claims brought in Indian forums under Indian law. That coverage may not respond to foreign proceedings or foreign judgments, and may contain jurisdictional limitations that exclude non-Indian claimants or non-Indian litigation. The patient may carry international health insurance or travel insurance providing some coverage for treatment costs, which typically does not include provision for legal claims against the treating hospital. Medical tourism facilitators may carry professional indemnity or public liability coverage in their home jurisdictions, with their own scope and exclusion architecture.

The consequence is that in a cross-border medical tourism claim, the question of which insurance policy responds to which aspect of the claim — in which forum, under whose law, managed by which insurer — is a separate and complex legal analysis that must run alongside the substantive liability investigation. Insurers on both sides of the transaction routinely face coverage disputes in medical tourism cases that require specialist analysis of the intersection between Indian and foreign insurance law, which is itself a rare specialist capacity.

Emerging Technologies and the Expanding Frontier of Cross-Border Healthcare Liability

The legal complexity of medical tourism litigation is being compounded by the emergence of technology-mediated healthcare relationships that extend the patient-clinician connection across borders before, during, and after physical treatment. Telemedicine consultations conducted by Indian clinicians with prospective patients in their home jurisdictions — preparatory consultations before travel for treatment — may themselves generate a duty of care whose breach gives rise to liability in the patient's home jurisdiction, even before the patient arrives in India. The Telemedicine Practice Guidelines 2020, issued by the National Medical Commission, govern the conduct of Indian practitioners in these consultations, but do not resolve the jurisdictional and applicable law questions that arise when the consultation takes place across national borders.

Post-operative remote monitoring — an increasingly standard feature of medical tourism arrangements, where an Indian hospital provides digital monitoring of a patient who has returned home after treatment — creates a continuing clinical relationship that extends across borders and may generate liability exposure in both jurisdictions simultaneously. AI-assisted diagnostic tools used to assess a patient's pre-travel suitability for a specific procedure, or to monitor post-operative recovery remotely, create an additional layer of liability architecture — product liability, platform liability, and clinical judgment liability — whose allocation across developer, deploying institution, and treating clinician is unsettled in Indian law and wholly uncharted in the cross-border context.

The result is that the medical tourism case of the next decade will frequently not be a single claim arising from a clinical event in an Indian hospital. It will be a connected series of clinical relationships — pre-travel telemedicine consultation, in-hospital treatment, AI-assisted monitoring, post-operative remote care — spanning multiple jurisdictions, governed by multiple legal frameworks, and generating liability exposure at each stage of the relationship.

The Specialist Intersection

What all of this reveals is that cross-border medical tourism litigation is not a species of domestic medical negligence practice with some international procedural complexity grafted onto it. It is a sui generis area of legal practice, requiring simultaneous competence in medical negligence law (applied comparatively across at least two legal systems), private international law (including jurisdiction, choice of law, and enforcement), contract law (the framework agreements governing the patient-hospital and patient-facilitator relationships), consumer protection law (in both jurisdictions), insurance law (including cross-border coverage analysis), and an understanding of the clinical governance and regulatory frameworks that govern healthcare in India.

No single practitioner can realistically claim deep expertise in all of these disciplines simultaneously. What a specialist can provide — and what a claimant or institutional defendant in a cross-border medical tourism dispute genuinely needs — is a legal advisor who understands the full architecture of the problem, who can identify where the specialist inputs are required and from whom, and who can co-ordinate the analytical framework across all dimensions of the dispute simultaneously rather than managing each dimension independently and hoping for consistency.

The Future of International Healthcare Disputes

The medical tourism sector will grow. Healthcare is becoming irreversibly globalised: telemedicine connects patients to clinicians across borders before travel, AI-assisted diagnostics generate clinical recommendations from servers in one jurisdiction for patients in another, and the datafication of health — through wearables, remote monitoring, and the Ayushman Bharat Digital Mission's interoperable health record architecture — means that the clinical relationship can exist and generate legal liability simultaneously in multiple jurisdictions.

The disputes that result will not be resolved by domestic medical negligence law applied in isolation. They will be resolved — or, more accurately, adjudicated and enforced, since many will resist tidy resolution — at the intersection of national legal systems, private international law principles, and regulatory frameworks whose boundaries are still being defined. The legal questions they generate will not merely be whether a clinical error occurred. They will be where that error can be litigated, which legal system should assess the clinical standard against which it is measured, and how any resulting judgment may be enforced against defendants, assets, and insurers distributed across jurisdictions with different enforcement relationships and different attitudes toward the recognition of foreign legal determinations.

This is, and will increasingly become, the frontier of international healthcare law. It demands a level of legal sophistication that the growth of medical tourism has created faster than the legal profession has developed specialists to address it. The gap between the sophistication of the legal questions and the specialist depth available to answer them is, for now, one of the defining features of this field. Closing that gap — through the development of practitioners who can genuinely advise across the full architecture of cross-border healthcare disputes — is the most significant challenge that the globalisation of healthcare is placing before the legal profession.

Hardi Goradia is a specialist healthcare law practitioner advising on medical negligence, healthcare regulation, criminal defence and professional accountability, and cross-border healthcare disputes across Indian and United Kingdom legal frameworks. This article is written for general legal commentary purposes and does not constitute legal advice on any specific matter.